Close
ACHEMA MIDDLE EAST 2026

Systech International And NKP Pharma Expand Presence In India

AI Summary

Systech International, a global technology leader in serialization, product safety, and consumer and brand protection, and NKP Pharma, an innovator in the field of designing and manufacturing pharmaceutical packaging machinery, announced a strategic agreement. The accord allows the two companies to provide software/hardware solutions to the Indian pharmaceutical industry that meet serialization and traceability regulations.

“Regionally specific serialization regulations are rapidly rolling out and Indian pharma must meet them to ensure full compliance in order to continue serving a global market,” said Harry Saint Preux, Director Global Alliances & Channels. “Our partnership with NKP allows for simplified regulatory compliance with a high end, integrated hardware and software solution.”

“Systech is the gold standard in the industry for providing premium solutions to meet global serialization and traceability mandates,” said Darshan Mevada, Managing Director of NKP. “Our relationship with Systech allows us to provide a fully integrated software hardware solution that will verifiably meet U.S. DSCSA, EU FMD, and other regulations,” said Mevada.

To discuss solutions, compliance, and integrated capabilities, meet with Systech and NKP Pharma at CPhI India, 28 30 November 2017 in Mumbai, Stand B50/Hall 6.

Systech’s software solutions are used by 19 of the top 20 global pharmaceutical companies. Systech is the only company that offers the full stack of Level 1 to Level 5 solutions. Systech, in tandem with NKP’s hardware and integration services, can provide the Indian industry with complete and unified serialization solutions that meet audit and validation requirements.

The pharmaceutical industry rarely announces its most significant shifts loudly. The signals are there — if you know where to look.

The Pharma Advancement briefing is how the sector’s most informed professionals stay ahead of those signals — covering drug development, regulatory affairs, manufacturing, and market access across every major region.

  • The stories pharmaceutical professionals will be discussing tomorrow, in your inbox today
  • Analysis that goes beyond the headline — written for readers who already understand the industry
  • The briefing that the sector’s most informed professionals open first

SUBSCRIBE OUR NEWSLETTER

WHITE PAPERS

RELATED ARTICLES